Expression and Prognostic Value of IFIT1 and IFITM3 in Head and Neck Squamous Cell Carcinoma
Abstract Objectives Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I interferon. The study aims to investigate the expression and clinical significance of IFIT1 and IFITM3 in head and neck squam...
Saved in:
Published in | American journal of clinical pathology Vol. 153; no. 5; pp. 618 - 629 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
US
Oxford University Press
15.04.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Objectives
Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I interferon. The study aims to investigate the expression and clinical significance of IFIT1 and IFITM3 in head and neck squamous cell carcinoma (HNSCC).
Methods
Immunohistochemistry was applied on tissue microarray to reveal IFIT1 and IFITM3 expression in 275 HNSCC, 69 dysplasia, and 42 normal mucosa samples. The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed.
Results
IFIT1 and IFITM3 were highly expressed in HNSCC tissues. High expression of IFIT1 and IFITM3 predicts a negative prognosis for patients (P < .01). IFIT1 and IFITM3 expression was associated with programmed cell death ligand 1, B7-H4, V-domain Ig suppressor of T-cell activation, indoleamine 2,3-dioxygenase, and macrophage marker immunoreactivity.
Conclusions
IFIT1 and IFITM3 were overexpressed in HNSCC and indicated poor prognoses for patients with HNSCC. IFIT1 and IFITM3 expression was correlated with several immune checkpoint molecules and tumor-associated macrophage markers. |
---|---|
AbstractList | The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed. Abstract Objectives Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I interferon. The study aims to investigate the expression and clinical significance of IFIT1 and IFITM3 in head and neck squamous cell carcinoma (HNSCC). Methods Immunohistochemistry was applied on tissue microarray to reveal IFIT1 and IFITM3 expression in 275 HNSCC, 69 dysplasia, and 42 normal mucosa samples. The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed. Results IFIT1 and IFITM3 were highly expressed in HNSCC tissues. High expression of IFIT1 and IFITM3 predicts a negative prognosis for patients (P < .01). IFIT1 and IFITM3 expression was associated with programmed cell death ligand 1, B7-H4, V-domain Ig suppressor of T-cell activation, indoleamine 2,3-dioxygenase, and macrophage marker immunoreactivity. Conclusions IFIT1 and IFITM3 were overexpressed in HNSCC and indicated poor prognoses for patients with HNSCC. IFIT1 and IFITM3 expression was correlated with several immune checkpoint molecules and tumor-associated macrophage markers. Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I interferon. The study aims to investigate the expression and clinical significance of IFIT1 and IFITM3 in head and neck squamous cell carcinoma (HNSCC). Immunohistochemistry was applied on tissue microarray to reveal IFIT1 and IFITM3 expression in 275 HNSCC, 69 dysplasia, and 42 normal mucosa samples. The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed. IFIT1 and IFITM3 were highly expressed in HNSCC tissues. High expression of IFIT1 and IFITM3 predicts a negative prognosis for patients (P < .01). IFIT1 and IFITM3 expression was associated with programmed cell death ligand 1, B7-H4, V-domain Ig suppressor of T-cell activation, indoleamine 2,3-dioxygenase, and macrophage marker immunoreactivity. IFIT1 and IFITM3 were overexpressed in HNSCC and indicated poor prognoses for patients with HNSCC. IFIT1 and IFITM3 expression was correlated with several immune checkpoint molecules and tumor-associated macrophage markers. Objectives Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I interferon. The study aims to investigate the expression and clinical significance of IFIT1 and IFITM3 in head and neck squamous cell carcinoma (HNSCC). Methods Immunohistochemistry was applied on tissue microarray to reveal IFIT1 and IFITM3 expression in 275 HNSCC, 69 dysplasia, and 42 normal mucosa samples. The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed. Results IFIT1 and IFITM3 were highly expressed in HNSCC tissues. High expression of IFIT1 and IFITM3 predicts a negative prognosis for patients (P < .01). IFIT1 and IFITM3 expression was associated with programmed cell death ligand 1, B7-H4, V-domain Ig suppressor of T-cell activation, indoleamine 2,3-dioxygenase, and macrophage marker immunoreactivity. Conclusions IFIT1 and IFITM3 were overexpressed in HNSCC and indicated poor prognoses for patients with HNSCC. IFIT1 and IFITM3 expression was correlated with several immune checkpoint molecules and tumor-associated macrophage markers. Objectives: Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I interferon. The study aims to investigate the expression and clinical significance of IFIT1 and IFITM3 in head and neck squamous cell carcinoma (HNSCC). Methods: Immunohistochemistry was applied on tissue microarray to reveal IFIT1 and IFITM3 expression in 275 HNSCC, 69 dysplasia, and 42 normal mucosa samples. The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed. Results: IFIT1 and IFITM3 were highly expressed in HNSCC tissues. High expression of IFIT1 and IFITM3 predicts a negative prognosis for patients (P < .01). IFIT1 and IFITM3 expression was associated with programmed cell death ligand 1, B7-H4, V-domain Ig suppressor of T-cell activation, indoleamine 2,3-dioxygenase, and macrophage marker immunoreactivity. Conclusions: IFIT1 and IFITM3 were overexpressed in HNSCC and indicated poor prognoses for patients with HNSCC. IFIT1 and IFITM3 expression was correlated with several immune checkpoint molecules and tumor-associated macrophage markers. Key Words: IFIT1; IFITM3; Head and neck squamous cell carcinoma; Prognosis; Macrophage OBJECTIVESInterferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I interferon. The study aims to investigate the expression and clinical significance of IFIT1 and IFITM3 in head and neck squamous cell carcinoma (HNSCC). METHODSImmunohistochemistry was applied on tissue microarray to reveal IFIT1 and IFITM3 expression in 275 HNSCC, 69 dysplasia, and 42 normal mucosa samples. The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed. RESULTSIFIT1 and IFITM3 were highly expressed in HNSCC tissues. High expression of IFIT1 and IFITM3 predicts a negative prognosis for patients (P < .01). IFIT1 and IFITM3 expression was associated with programmed cell death ligand 1, B7-H4, V-domain Ig suppressor of T-cell activation, indoleamine 2,3-dioxygenase, and macrophage marker immunoreactivity. CONCLUSIONSIFIT1 and IFITM3 were overexpressed in HNSCC and indicated poor prognoses for patients with HNSCC. IFIT1 and IFITM3 expression was correlated with several immune checkpoint molecules and tumor-associated macrophage markers. |
Audience | Professional Academic |
Author | Wu, Cong-Cong Zhang, Wen-Feng Li, Hao Xiao, Yao Chen, Lei Yang, Lei-Lei Mao, Liang Sun, Zhi-Jun |
Author_xml | – sequence: 1 givenname: Hao surname: Li fullname: Li, Hao organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China – sequence: 2 givenname: Lei-Lei surname: Yang fullname: Yang, Lei-Lei organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China – sequence: 3 givenname: Cong-Cong surname: Wu fullname: Wu, Cong-Cong organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China – sequence: 4 givenname: Yao surname: Xiao fullname: Xiao, Yao organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China – sequence: 5 givenname: Liang surname: Mao fullname: Mao, Liang organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China – sequence: 6 givenname: Lei surname: Chen fullname: Chen, Lei organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China – sequence: 7 givenname: Wen-Feng surname: Zhang fullname: Zhang, Wen-Feng organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China – sequence: 8 givenname: Zhi-Jun orcidid: 0000-0003-0932-8013 surname: Sun fullname: Sun, Zhi-Jun email: sunzj@whu.edu.cn organization: The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) & Key Laboratory of Oral Biomedicine Ministry of Education, School & Hospital of Stomatology, Wuhan, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31977029$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kd1LHDEUxYModdU--S6BQhHKaL5mMnmUxe0u2FZQ-ySEbJKRrDPJbLID1b_erKsVi5TAzeXe3z0cOHtg2wdvATjE6AQjQU_VQvenavlIULkFRlgwWnBOyDYYIYRIITCnu2AvpQVCmNSIfQK7FAvOEREjcHv-p482JRc8VN7AyxjufEgrp-Fv1Q4WhgbOJrNr_Lxddz8odB5OrTLPo59W38Or5aC6MCQ4tm0Lxypq50OnDsBOo9pkP7_8--Bmcn49nhYXv77PxmcXhWYlWRWEcoLntS2J0XOqkc6VcF1TzXBVG2bqxihkuRb1HJeGMis4qlmDuKaUK0P3wfFGt49hOdi0kp1LOltR3mZXklDGSMUorzL65R90EYbosztJGClLjgXCb9Sdaq10vgmrqPRaVJ5V2TOrOBWZOvmAys_YzukcUuPy_N3Bt82BjiGlaBvZR9ep-CAxkuss5TpLucky00cvVod5Z81f9jW8DHzdAGHo_6v0BGyupYc |
CitedBy_id | crossref_primary_10_3390_cells10051171 crossref_primary_10_1007_s12032_024_02308_6 crossref_primary_10_1186_s13062_023_00422_5 crossref_primary_10_1007_s42979_022_01492_4 crossref_primary_10_3389_fimmu_2022_1042368 crossref_primary_10_3389_fonc_2020_593245 crossref_primary_10_1186_s12957_023_03274_5 crossref_primary_10_1038_s41598_024_51427_7 crossref_primary_10_1007_s12033_021_00439_z crossref_primary_10_3389_fonc_2020_607622 crossref_primary_10_1080_21655979_2021_2024333 crossref_primary_10_2147_IDR_S328197 crossref_primary_10_1016_j_omto_2021_07_002 |
Cites_doi | 10.1007/s12094-012-0991-z 10.3892/or.2014.3522 10.1007/s12094-017-1776-1 10.1038/nrc1782 10.1093/ajcp/aqy029 10.1038/ncomms14391 10.1200/JCO.2015.61.1509 10.1186/1471-2377-13-210 10.1158/1078-0432.CCR-10-2729 10.1038/nri1961 10.1002/hed.25507 10.1038/nri3344 10.1093/nar/gkx247 10.1111/1759-7714.12488 10.1038/nrc2090 10.1007/s12094-012-0867-2 10.1006/geno.1994.1591 10.3322/caac.21442 10.1371/journal.pone.0051862 10.1038/nri2326 10.1016/j.oraloncology.2017.05.004 10.1038/s41568-019-0106-z 10.1016/j.immuni.2016.05.002 10.1016/j.ccell.2015.02.015 10.1111/tbj.12097 10.1038/nrclinonc.2017.101 10.1080/000164802760057527 10.1038/s41571-018-0142-8 10.1016/0092-8674(84)90270-8 10.3892/or.2013.2428 10.1038/nrc.2017.17 10.1073/pnas.0809242105 10.1038/onc.2011.393 10.18632/oncotarget.17547 10.18632/oncotarget.13328 10.1111/apm.12692 10.3389/fonc.2019.00091 10.1002/hed.24406 10.1007/s00262-017-1968-0 10.1007/s00262-016-1867-9 10.1038/ni.2048 10.1038/nature00927 10.18632/oncotarget.5955 10.1002/ijc.29210 10.1016/j.immuni.2015.09.001 10.1038/nri3581 10.1111/j.1349-7006.2012.02211.x 10.1016/j.oraloncology.2011.03.007 |
ContentType | Journal Article |
Copyright | American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020 American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. COPYRIGHT 2020 Oxford University Press American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com |
Copyright_xml | – notice: American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020 – notice: American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. – notice: COPYRIGHT 2020 Oxford University Press – notice: American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com |
DBID | NPM AAYXX CITATION 3V. 7RV 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. KB0 LK8 M0S M1P M7P NAPCQ PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1093/ajcp/aqz205 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database Nursing & Allied Health Premium ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | PubMed CrossRef ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed ProQuest Central Student CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology |
EISSN | 1943-7722 |
EndPage | 629 |
ExternalDocumentID | A645246739 10_1093_ajcp_aqz205 31977029 10.1093/ajcp/aqz205 |
Genre | Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- .55 0R~ 1CY 23M 2WC 4.4 48X 53G 5GY 5RE 5WD 6J9 7RV 7X7 88E 8FE 8FH 8FI 8FJ AABZA AACZT AAIMJ AAMDB AAMVS AAPQZ AAPXW AAQQT AARHZ AASNB AAUAY AAUQX AAVAP AAWTL ABCQX ABEUO ABIXL ABJNI ABLJU ABMNT ABNHQ ABPPZ ABPTD ABQNK ABUWG ABWST ABXVV ACGFO ACGFS ACPRK ACUFI ACUTJ ACYHN ADBBV ADFRT ADGZP ADHKW ADIPN ADQBN ADRTK ADVEK AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFZL AFGWE AFIYH AFKRA AFOFC AFXEN AGINJ AGQXC AGSYK AGUTN AHMBA AJEEA ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQC APIBT ARIXL ATGXG AVWKF AYOIW BAWUL BAYMD BBNVY BCRHZ BENPR BEYMZ BHONS BHPHI BKEYQ BPHCQ BQDIO BSWAC BTRTY BVRKM BVXVI C45 CCPQU CDBKE CS3 DAKXR DIK DILTD E3Z EBS ENERS EX3 F5P FECEO FHSFR FLUFQ FOEOM FOTVD FQBLK FYUFA GAUVT GJXCC GX1 H13 HCIFZ HMCUK IAO IH2 IHR INH ITC J21 KBUDW KOP KQ8 KSI KSN L7B LID LK8 LSO M1P M7P MHKGH NAPCQ NLBLG NOMLY NOYVH O9- OAUYM OAWHX OBOKY OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF P2P P6G PAFKI PEELM PQQKQ PROAC PSQYO ROX ROZ RUSNO SJN TEORI TJX TLC TPV TR2 TWZ UKHRP W8F WH7 WOW X7M YAYTL YKOAZ YXANX EMB NPM AAYXX CITATION AABJS AABMN AAESY ABSAR ABXZS ACIMA ADEIU ADJQC ADORX ADQLU ADRIX AHPSJ AIKOY AIMBJ ALXQX ASMCH AZQFJ BGYMP BYORX CASEJ DPPUQ ZA5 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c452t-23721b8e52dcb3c0ccb327c83c4168d4d8fda0e7c98b15d34e97084f07c337ad3 |
IEDL.DBID | 7X7 |
ISSN | 0002-9173 |
IngestDate | Sat Oct 05 05:17:35 EDT 2024 Thu Oct 10 21:51:28 EDT 2024 Thu Feb 22 23:55:03 EST 2024 Fri Feb 02 04:18:10 EST 2024 Thu Sep 26 18:41:43 EDT 2024 Wed Oct 16 00:45:53 EDT 2024 Wed Sep 11 04:40:05 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | IFITM3 Head and neck squamous cell carcinoma Prognosis IFIT1 Macrophage |
Language | English |
License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c452t-23721b8e52dcb3c0ccb327c83c4168d4d8fda0e7c98b15d34e97084f07c337ad3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-0932-8013 |
OpenAccessLink | https://academic.oup.com/ajcp/article-pdf/153/5/618/33049421/aqz205.pdf |
PMID | 31977029 |
PQID | 2425571901 |
PQPubID | 586299 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_2344264376 proquest_journals_2425571901 gale_infotracmisc_A645246739 gale_infotracacademiconefile_A645246739 crossref_primary_10_1093_ajcp_aqz205 pubmed_primary_31977029 oup_primary_10_1093_ajcp_aqz205 |
PublicationCentury | 2000 |
PublicationDate | 2020-04-15 |
PublicationDateYYYYMMDD | 2020-04-15 |
PublicationDate_xml | – month: 04 year: 2020 text: 2020-04-15 day: 15 |
PublicationDecade | 2020 |
PublicationPlace | US |
PublicationPlace_xml | – name: US – name: England – name: Chicago |
PublicationTitle | American journal of clinical pathology |
PublicationTitleAlternate | Am J Clin Pathol |
PublicationYear | 2020 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Müller (2020041521553931400_CIT0044) 2017; 8 Grimm (2020041521553931400_CIT0006) 2012; 14 De Marzo (2020041521553931400_CIT0050) 2007; 7 Yu (2020041521553931400_CIT0030) 2015; 6 Li (2020041521553931400_CIT0040) 2019;25:157-167 Brierley (2020041521553931400_CIT0026) 2016 Li (2020041521553931400_CIT0019) 2011; 17 Friedman (2020041521553931400_CIT0015) 1984; 38 Geng (2020041521553931400_CIT0051) 2019; 9 Hu (2020041521553931400_CIT0017) 2014; 32 Saitou (2020041521553931400_CIT0016) 2002; 418 Pichlmair (2020041521553931400_CIT0012) 2011; 12 Weichselbaum (2020041521553931400_CIT0014) 2008; 105 Cui (2020041521553931400_CIT0022) 2015; 37 Maroto (2020041521553931400_CIT0034) 2013; 15 Ryu (2020041521553931400_CIT0047) 2019; 41 Diamond (2020041521553931400_CIT0009) 2013; 13 Tang (2020041521553931400_CIT0027) 2017; 45 Ferlay (2020041521553931400_CIT0002) 2015; 136 Jønsson (2020041521553931400_CIT0048) 2017; 8 Iglesias Docampo (2020041521553931400_CIT0005) 2018; 20 Bluyssen (2020041521553931400_CIT0011) 1994; 24 Wu (2020041521553931400_CIT0032) 2017; 66 Ali (2020041521553931400_CIT0003) 2017; 70 Cheriyath (2020041521553931400_CIT0037) 2012; 31 de Visser (2020041521553931400_CIT0036) 2006; 6 Jia (2020041521553931400_CIT0021) 2017; 8 Ivashkiv (2020041521553931400_CIT0010) 2014; 14 Biswas (2020041521553931400_CIT0007) 2015; 43 Laimer (2020041521553931400_CIT0033) 2011; 47 Gotwals (2020041521553931400_CIT0045) 2017; 17 Inagi (2020041521553931400_CIT0004) 2002 Li (2020041521553931400_CIT0028) 2018; 150 Siegel (2020041521553931400_CIT0001) 2018; 68 Han (2020041521553931400_CIT0049) 2011; 25 Piccaluga (2020041521553931400_CIT0039) 2017; 125 Dunn (2020041521553931400_CIT0008) 2006; 6 Zou (2020041521553931400_CIT0043) 2008; 8 O’Donnell (2020041521553931400_CIT0052) 2019; 16 Danish (2020041521553931400_CIT0035) 2013; 19 Wu (2020041521553931400_CIT0031) 2016; 65 Nguyen (2020041521553931400_CIT0042) 2016; 38 Kondo (2020041521553931400_CIT0038) 2012; 103 Lemos (2020041521553931400_CIT0025) 2019; 19 Budczies (2020041521553931400_CIT0029) 2012; 7 Visser (2020041521553931400_CIT0013) 2017; 8 Zhao (2020041521553931400_CIT0020) 2013; 13 Fridman (2020041521553931400_CIT0023) 2017; 14 Ferris (2020041521553931400_CIT0041) 2015; 33 Yang (2020041521553931400_CIT0018) 2013; 30 Schildberg (2020041521553931400_CIT0024) 2016; 44 Ruffell (2020041521553931400_CIT0046) 2015; 27 |
References_xml | – volume: 15 start-page: 698 year: 2013 ident: 2020041521553931400_CIT0034 article-title: Phase II trial of sequential subcutaneous interleukin-2 plus interferon alpha followed by sorafenib in renal cell carcinoma (RCC) publication-title: Clin Transl Oncol. doi: 10.1007/s12094-012-0991-z contributor: fullname: Maroto – volume: 32 start-page: 2648 year: 2014 ident: 2020041521553931400_CIT0017 article-title: Mechanism and biological significance of the overexpression of IFITM3 in gastric cancer publication-title: Oncol Rep. doi: 10.3892/or.2014.3522 contributor: fullname: Hu – volume: 20 start-page: 75 year: 2018 ident: 2020041521553931400_CIT0005 article-title: SEOM clinical guidelines for the treatment of head and neck cancer (2017) publication-title: Clin Transl Oncol. doi: 10.1007/s12094-017-1776-1 contributor: fullname: Iglesias Docampo – volume: 6 start-page: 24 year: 2006 ident: 2020041521553931400_CIT0036 article-title: Paradoxical roles of the immune system during cancer development publication-title: Nat Rev Cancer. doi: 10.1038/nrc1782 contributor: fullname: de Visser – volume: 150 start-page: 74 year: 2018 ident: 2020041521553931400_CIT0028 article-title: Overexpression of Golgi phosphoprotein 2 is associated with poor prognosis in oral squamous cell carcinoma publication-title: Am J Clin Pathol. doi: 10.1093/ajcp/aqy029 contributor: fullname: Li – volume: 8 start-page: 14391 year: 2017 ident: 2020041521553931400_CIT0048 article-title: IFI16 is required for DNA sensing in human macrophages by promoting production and function of cGAMP publication-title: Nat Commun. doi: 10.1038/ncomms14391 contributor: fullname: Jønsson – volume: 33 start-page: 3293 year: 2015 ident: 2020041521553931400_CIT0041 article-title: Immunology and immunotherapy of head and neck cancer publication-title: J Clin Oncol. doi: 10.1200/JCO.2015.61.1509 contributor: fullname: Ferris – volume: 13 start-page: 210 year: 2013 ident: 2020041521553931400_CIT0020 article-title: The role of IFITM3 in the growth and migration of human glioma cells publication-title: BMC Neurol. doi: 10.1186/1471-2377-13-210 contributor: fullname: Zhao – volume: 17 start-page: 3558 year: 2011 ident: 2020041521553931400_CIT0019 article-title: KLF4-mediated negative regulation of IFITM3 expression plays a critical role in colon cancer pathogenesis publication-title: Clin Cancer Res. doi: 10.1158/1078-0432.CCR-10-2729 contributor: fullname: Li – volume: 6 start-page: 836 year: 2006 ident: 2020041521553931400_CIT0008 article-title: Interferons, immunity and cancer immunoediting publication-title: Nat Rev Immunol. doi: 10.1038/nri1961 contributor: fullname: Dunn – volume: 37 start-page: 352 year: 2015 ident: 2020041521553931400_CIT0022 article-title: Expression of IFITM3 in colorectal carcinoma and its clinical significance publication-title: Zhonghua Zhong Liu Za Zhi. contributor: fullname: Cui – volume: 41 start-page: 198 year: 2019 ident: 2020041521553931400_CIT0047 article-title: Characterization of head and neck squamous cell carcinoma arising in young patients: particular focus on molecular alteration and tumor immunity publication-title: Head Neck. doi: 10.1002/hed.25507 contributor: fullname: Ryu – volume: 13 start-page: 46 year: 2013 ident: 2020041521553931400_CIT0009 article-title: The broad-spectrum antiviral functions of IFIT and IFITM proteins publication-title: Nat Rev Immunol. doi: 10.1038/nri3344 contributor: fullname: Diamond – volume: 45 start-page: W98 year: 2017 ident: 2020041521553931400_CIT0027 article-title: GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkx247 contributor: fullname: Tang – volume: 8 start-page: 592 year: 2017 ident: 2020041521553931400_CIT0021 article-title: Overexpression of IFITM3 predicts poor prognosis in stage IIA esophageal squamous cell carcinoma after Ivor Lewis esophagectomy publication-title: Thorac Cancer. doi: 10.1111/1759-7714.12488 contributor: fullname: Jia – volume: 7 start-page: 256 year: 2007 ident: 2020041521553931400_CIT0050 article-title: Inflammation in prostate carcinogenesis publication-title: Nat Rev Cancer. doi: 10.1038/nrc2090 contributor: fullname: De Marzo – volume: 14 start-page: 870 year: 2012 ident: 2020041521553931400_CIT0006 article-title: Prognostic value of clinicopathological parameters and outcome in 484 patients with oral squamous cell carcinoma: microvascular invasion (V+) is an independent prognostic factor for OSCC publication-title: Clin Transl Oncol. doi: 10.1007/s12094-012-0867-2 contributor: fullname: Grimm – volume: 24 start-page: 137 year: 1994 ident: 2020041521553931400_CIT0011 article-title: Structure, chromosome localization, and regulation of expression of the interferon-regulated mouse Ifi54/Ifi56 gene family publication-title: Genomics. doi: 10.1006/geno.1994.1591 contributor: fullname: Bluyssen – volume: 68 start-page: 7 year: 2018 ident: 2020041521553931400_CIT0001 article-title: Cancer statistics, 2018 publication-title: CA Cancer J Clin. doi: 10.3322/caac.21442 contributor: fullname: Siegel – volume: 7 start-page: e51862 year: 2012 ident: 2020041521553931400_CIT0029 article-title: Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization publication-title: PLoS One. doi: 10.1371/journal.pone.0051862 contributor: fullname: Budczies – volume: 8 start-page: 467 year: 2008 ident: 2020041521553931400_CIT0043 article-title: Inhibitory B7-family molecules in the tumour microenvironment publication-title: Nat Rev Immunol. doi: 10.1038/nri2326 contributor: fullname: Zou – volume: 70 start-page: 23 year: 2017 ident: 2020041521553931400_CIT0003 article-title: Genetic etiology of oral cancer publication-title: Oral Oncol. doi: 10.1016/j.oraloncology.2017.05.004 contributor: fullname: Ali – volume: 19 start-page: 162 year: 2019 ident: 2020041521553931400_CIT0025 article-title: Immune control by amino acid catabolism during tumorigenesis and therapy publication-title: Nat Rev Cancer. doi: 10.1038/s41568-019-0106-z contributor: fullname: Lemos – volume: 44 start-page: 955 year: 2016 ident: 2020041521553931400_CIT0024 article-title: Coinhibitory pathways in the B7-CD28 ligand-receptor family publication-title: Immunity. doi: 10.1016/j.immuni.2016.05.002 contributor: fullname: Schildberg – volume: 27 start-page: 462 year: 2015 ident: 2020041521553931400_CIT0046 article-title: Macrophages and therapeutic resistance in cancer publication-title: Cancer Cell. doi: 10.1016/j.ccell.2015.02.015 contributor: fullname: Ruffell – volume: 25 start-page: 531 year: 2011 ident: 2020041521553931400_CIT0049 article-title: IFITM6 expression is increased in macrophages of tumor-bearing mice publication-title: Oncol Rep. contributor: fullname: Han – volume: 19 start-page: 231 year: 2013 ident: 2020041521553931400_CIT0035 article-title: Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) as a prognostic marker for local control in T1-2 N0 breast cancer treated with breast-conserving surgery and radiation therapy (BCS + RT) publication-title: Breast J. doi: 10.1111/tbj.12097 contributor: fullname: Danish – volume-title: TNM Classification of Malignant Tumours year: 2016 ident: 2020041521553931400_CIT0026 contributor: fullname: Brierley – volume: 14 start-page: 717 year: 2017 ident: 2020041521553931400_CIT0023 article-title: The immune contexture in cancer prognosis and treatment publication-title: Nat Rev Clin Oncol. doi: 10.1038/nrclinonc.2017.101 contributor: fullname: Fridman – start-page: 25 year: 2002 ident: 2020041521553931400_CIT0004 article-title: Treatment effects in patients with squamous cell carcinoma of the oral cavity publication-title: Acta Otolaryngol Suppl. doi: 10.1080/000164802760057527 contributor: fullname: Inagi – volume: 16 start-page: 151 year: 2019 ident: 2020041521553931400_CIT0052 article-title: Cancer immunoediting and resistance to T cell-based immunotherapy publication-title: Nat Rev Clin Oncol. doi: 10.1038/s41571-018-0142-8 contributor: fullname: O’Donnell – volume: 38 start-page: 745 year: 1984 ident: 2020041521553931400_CIT0015 article-title: Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells publication-title: Cell. doi: 10.1016/0092-8674(84)90270-8 contributor: fullname: Friedman – volume: 30 start-page: 171 year: 2013 ident: 2020041521553931400_CIT0018 article-title: Knockdown of interferon-induced transmembrane protein 3 expression suppresses breast cancer cell growth and colony formation and affects the cell cycle publication-title: Oncol Rep. doi: 10.3892/or.2013.2428 contributor: fullname: Yang – volume: 17 start-page: 286 year: 2017 ident: 2020041521553931400_CIT0045 article-title: Prospects for combining targeted and conventional cancer therapy with immunotherapy publication-title: Nat Rev Cancer. doi: 10.1038/nrc.2017.17 contributor: fullname: Gotwals – volume: 105 start-page: 18490 year: 2008 ident: 2020041521553931400_CIT0014 article-title: An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer publication-title: Proc Natl Acad Sci U S A. doi: 10.1073/pnas.0809242105 contributor: fullname: Weichselbaum – year: 2019;25:157-167 ident: 2020041521553931400_CIT0040 article-title: DDR2 and IFITM1 are prognostic markers in gallbladder squamous cell/adenosquamous carcinomas and adenocarcinomas publication-title: Pathol Oncol Res. contributor: fullname: Li – volume: 31 start-page: 2222 year: 2012 ident: 2020041521553931400_CIT0037 article-title: G1P3, an interferon- and estrogen-induced survival protein contributes to hyperplasia, tamoxifen resistance and poor outcomes in breast cancer publication-title: Oncogene. doi: 10.1038/onc.2011.393 contributor: fullname: Cheriyath – volume: 8 start-page: 52889 year: 2017 ident: 2020041521553931400_CIT0044 article-title: PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma publication-title: Oncotarget. doi: 10.18632/oncotarget.17547 contributor: fullname: Müller – volume: 8 start-page: 5566 year: 2017 ident: 2020041521553931400_CIT0013 article-title: Prognostic gene expression profiling in esophageal cancer: a systematic review publication-title: Oncotarget. doi: 10.18632/oncotarget.13328 contributor: fullname: Visser – volume: 125 start-page: 511 year: 2017 ident: 2020041521553931400_CIT0039 article-title: IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia publication-title: Apmis. doi: 10.1111/apm.12692 contributor: fullname: Piccaluga – volume: 9 start-page: 91 year: 2019 ident: 2020041521553931400_CIT0051 article-title: Identification of potential candidate genes of oral cancer in response to chronic infection with Porphyromonas gingivalis using bioinformatical analyses publication-title: Front Oncol. doi: 10.3389/fonc.2019.00091 contributor: fullname: Geng – volume: 38 start-page: 1074 year: 2016 ident: 2020041521553931400_CIT0042 article-title: Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma publication-title: Head Neck. doi: 10.1002/hed.24406 contributor: fullname: Nguyen – volume: 66 start-page: 627 year: 2017 ident: 2020041521553931400_CIT0032 article-title: Expression of VISTA correlated with immunosuppression and synergized with CD8 to predict survival in human oral squamous cell carcinoma publication-title: Cancer Immunol Immunother. doi: 10.1007/s00262-017-1968-0 contributor: fullname: Wu – volume: 65 start-page: 1035 year: 2016 ident: 2020041521553931400_CIT0031 article-title: B7-H4 expression indicates poor prognosis of oral squamous cell carcinoma publication-title: Cancer Immunol Immunother. doi: 10.1007/s00262-016-1867-9 contributor: fullname: Wu – volume: 12 start-page: 624 year: 2011 ident: 2020041521553931400_CIT0012 article-title: IFIT1 is an antiviral protein that recognizes 5′-triphosphate RNA publication-title: Nat Immunol. doi: 10.1038/ni.2048 contributor: fullname: Pichlmair – volume: 418 start-page: 293 year: 2002 ident: 2020041521553931400_CIT0016 article-title: A molecular programme for the specification of germ cell fate in mice publication-title: Nature. doi: 10.1038/nature00927 contributor: fullname: Saitou – volume: 6 start-page: 42067 year: 2015 ident: 2020041521553931400_CIT0030 article-title: PD-1 blockade attenuates immunosuppressive myeloid cells due to inhibition of CD47/SIRPα axis in HPV negative head and neck squamous cell carcinoma publication-title: Oncotarget. doi: 10.18632/oncotarget.5955 contributor: fullname: Yu – volume: 136 start-page: E359 year: 2015 ident: 2020041521553931400_CIT0002 article-title: Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 publication-title: Int J Cancer. doi: 10.1002/ijc.29210 contributor: fullname: Ferlay – volume: 43 start-page: 435 year: 2015 ident: 2020041521553931400_CIT0007 article-title: Metabolic reprogramming of immune cells in cancer progression publication-title: Immunity. doi: 10.1016/j.immuni.2015.09.001 contributor: fullname: Biswas – volume: 14 start-page: 36 year: 2014 ident: 2020041521553931400_CIT0010 article-title: Regulation of type I interferon responses publication-title: Nat Rev Immunol. doi: 10.1038/nri3581 contributor: fullname: Ivashkiv – volume: 103 start-page: 782 year: 2012 ident: 2020041521553931400_CIT0038 article-title: Overexpression of the DNA sensor proteins, absent in melanoma 2 and interferon-inducible 16, contributes to tumorigenesis of oral squamous cell carcinoma with p53 inactivation publication-title: Cancer Sci. doi: 10.1111/j.1349-7006.2012.02211.x contributor: fullname: Kondo – volume: 47 start-page: 352 year: 2011 ident: 2020041521553931400_CIT0033 article-title: Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas publication-title: Oral Oncol. doi: 10.1016/j.oraloncology.2011.03.007 contributor: fullname: Laimer |
SSID | ssj0012804 |
Score | 2.4409955 |
Snippet | Abstract
Objectives
Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly... Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by type I... Objectives: Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by... The clinicopathologic features associated with IFIT1 and IFITM3 expression in HNSCC patients were analyzed. Objectives Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by... OBJECTIVESInterferon-induced protein with tetratricopeptide repeats 1 (IFIT1) and interferon-induced transmembrane protein 3 (IFITM3) are commonly induced by... |
SourceID | proquest gale crossref pubmed oup |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 618 |
SubjectTerms | Apoptosis B7 antigen Cell activation Cell death Dysplasia Genetic aspects Head & neck cancer Head and neck cancer Immune checkpoint Immunoglobulins Immunohistochemistry Interferon Lymphocytes T Macrophages Medical prognosis Mucosa Prognosis Squamous cell carcinoma Tissue microarrays Tryptophan 2,3-dioxygenase |
Title | Expression and Prognostic Value of IFIT1 and IFITM3 in Head and Neck Squamous Cell Carcinoma |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31977029 https://www.proquest.com/docview/2425571901 https://search.proquest.com/docview/2344264376 |
Volume | 153 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_BJhAvCMZXoAwjTeIpamI7tfOERtWqQ1o1wYb6gBQ5tiMNStJ2rQT89dwlbqFC2ksUxbEt3Z3Pv_Od7wBOBuTecypF4S1dLE0qKQekjLNKuNxKQZCZoi2mg8mV_DjLZuHA7SaEVW51YquoXWPpjLxP0DhTtH29XyxjqhpF3tVQQuMuHKYcwQTKs5rtDC5UvYncwl80S0S4n4dGfN98s4u-Wf7mVLfunx0p6OW9y27_Yc527xk_gocBNLLTjsuP4Y6vj-BeV0by1xHcPw8O8ifwdfQzRLbWzNSOXawaiqTDfuyLmW88ayp2Nj67TNtWejsX7LpmE2R1-2nq7Xf2ebkxdCTAhn4-Z0MqN1Q3P8xTuBqPLoeTOBRQiK3M-DrmAu27UvuMO1sKm1h8cmW1sAjDtJNOV84kXtlcl2nmhPS5SrSsEmWFUMaJZ3BQN7V_Acxqh8upoqI22FnxUicDXaVZyVOfu8REcLIlYrHo8mQUnX9bFETroqN1BO-IwAWtnvXKWBMuAeAklIeqOCU_K-pukUfQ2_sTpd7uNb9BFt0-VW_LviKsy5virxRF8HbXTGNTrFntkbQFF5JgImreCJ53bN_NgwpLqYTnL28f_BU84GSXU07IrAcH69XGv0bwsi6PWwk9hsMPo-nFpz-5J-of |
link.rule.ids | 315,786,790,12083,21416,27955,27956,31752,31753,33777,33778,43343,43838,74100,74657 |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dixMxEB_0xI8X0dPT1epFOPBp6W6SbXaf5ChXWr0WwZ70QQjZJAtq3W17Lah_vTPdtFqEe1mWzSaBmcnkN5nJDMBZj9x7TqUovKWLpUkl5YCUcVYJV1gpCDJTtMWkN7yS72fZLBy4XYewyp1O3Cpq11g6I-8SNM4UbV_vFsuYqkaRdzWU0LgNd6QQkuRczfYGF6reRO7gL5olItzPQyO-a77ZRdcsf3OqW_fPjhT08sFlt_8w53bvGTyChwE0svOWy4_hlq-P4W5bRvLXMdwbBwf5E_hy8TNEttbM1I59XDUUSYf92Gcz33jWVGw0GE3TbSu9jQX7WrMhsnr7aeLtd_ZpuTF0JMD6fj5nfSo3VDc_zFO4GlxM-8M4FFCIrcz4OuYC7bsy9xl3thQ2sfjkyubCIgzLnXR55UzilS3yMs2ckL5QSS6rRFkhlHHiBI7qpvbPgdnc4XKqqKgNdla8zJNeXqVZyVNfuMREcLYjol60eTJ0698WmmitW1pH8JYIrGn1rFfGmnAJACehPFT6nPysqLtFEUHn4E-UenvQfIosunmqzo59OqzLa_1XiiJ4s2-msSnWrPZIWs2FJJiImjeCZy3b9_OgwlIq4cWLmwc_hfvD6fhSX44mH17CA042OuWHzDpwtF5t_CsEMuvy9VZa_wCAUety |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db9Mw8ARDTLwgGF-Bwow0iaeoie3UyROayqoWWDWJDfUByXJsRwJK0natBPx67hK3UCHtJYri2Jbu-3znO4CTAYX3nEqReEsXS5NKqgEp46wSrrBSkMlM2RbTwfhKvp9ls5D_dB3SKrcysRXUrrF0Rt4n0zhTpL76VUiLuHg3ertYxtRBiiKtoZ3GbbiDWjKhNg5qtnO-UAwncmsKo4siwl09dOj75ptd9M3yN6cedv9opyCj9y6-_Wd_tnpo9ADuBwOSnXYYfwi3fH0Ed7uWkr-O4PA8BMsfwZeznyHLtWamduxi1VBWHc5jn81841lTsclocpm2o_R2LtjXmo0R7e2nqbff2aflxtDxABv6-ZwNqfVQ3fwwj-FqdHY5HMehmUJsZcbXMRfo65W5z7izpbCJxSdXNhcWTbLcSZdXziRe2SIv08wJ6QuV5LJKlBVCGSeewEHd1P4ZMJs7ZK2KGtzgZMXLPBnkVZqVPPWFS0wEJ1sg6kVXM0N3sW6hCda6g3UEbwjAmjhpvTLWhAsBuAnVpNKnFHNFOS6KCHp7fyIH2L3hY0TRzVv1tujTgUev9V-KiuD1bpjWpryz2iNoNReSTEaUwhE87dC-2weFl1IJL57fvPgxHCKh6o-T6YcXcI-Tu06lIrMeHKxXG_8SbZp1-aol1j-juO-e |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expression+and+Prognostic+Value+of+IFIT1+and+IFITM3+in+Head+and+Neck+Squamous+Cell+Carcinoma&rft.jtitle=American+journal+of+clinical+pathology&rft.au=Li%2C+Hao&rft.au=Yang%2C+Lei-Lei&rft.au=Wu%2C+Cong-Cong&rft.au=Xiao%2C+Yao&rft.date=2020-04-15&rft.issn=0002-9173&rft.eissn=1943-7722&rft.volume=153&rft.issue=5&rft.spage=618&rft.epage=629&rft_id=info:doi/10.1093%2Fajcp%2Faqz205&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_ajcp_aqz205 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0002-9173&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0002-9173&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0002-9173&client=summon |